Primary Antibodies
Primary antibodies are immunoglobulins that recognize and bind to a specific antigen of interest with high affinity and specificity to purify, detect, and measure that antigen. Includes antibody pairs for specific biochemical applications.
All Primary Antibodies
(176,912)
Primary Antibody Matched Pairs
(31)
Protein Interaction Antibody Pairs
(5)
Protein Phosphorylation Antibody Pairs
(1)
Résultats de la recherche filtrée
Les produits de certains de nos fournisseurs ne s'affichent pas dans les résultats de la recherche filtrée. Veuillez
supprimer tous les filtres
pour voir ces produits.
Recherche par mot-clé:
Effacer la recherche
1
–
15
de
163,636
résultats
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2a κ |
| Conjugué | Alexa Fluor 514 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P46013 |
| Expression | Mki67 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 4288 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Rat |
| Symboles de gène(s) | Mki67 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | antigen identified by monoclonal antibody Ki 67; antigen identified by monoclonal antibody Ki-67; Antigen identified by monoclonal antibody Ki-67 homolog; Antigen KI-67; Antigen KI-67 homolog; antigen KI-67; proliferation marker protein Ki-67; antigen KI-67-like; cb31; D630048A14Rik; I79_022666; Ki67; Ki-67; KIA; LOW QUALITY PROTEIN: proliferation marker protein Ki-67; marker of proliferation Ki-67; MIB-; MIB-1; Mki67; PPP1R105; Proliferation marker protein Ki-67; proliferation-related Ki-67 antigen; protein phosphatase 1, regulatory subunit 105; RP11-380J17.2; sb:cb31; si:ch211-250b22.7; unnamed protein product; wu:fa11g09; wu:fb57a07; wu:fi14e05 |
| Clone | SolA15 |
| Antigène | Ki-67 |
Invitrogen™ CD249 Recombinant Rabbit Monoclonal Antibody (23GB5325)
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Rabbit Recombinant Monoclonal Antibody
| Applications | Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG |
| Conjugué | Unconjugated |
| Espèces cibles | Human,Mouse,Rat |
| Concentration | 1.5 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | -20°C |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P16406, P50123, Q07075 |
| Immunogène | A synthesized peptide derived from human Aminopeptidase A/CD249 (900-957AA). |
| Expression | Enpep |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 13809, 2028, 64017 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | Enpep |
| Formule | PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 |
| Alias de gène | 6030431M22Rik; Aminopeptidase A; aminopeptidase-A; APA; AP-A; BP1; Bp-1/6C3; BP-1/6C3 antigen; CD249; differentiation antigen gp160; EAP; ENPEP; Glutamyl aminopeptidase; glutamyl aminopeptidase (aminopeptidase A); gp160; Ly51; Ly-51 |
| Clone | 23GB5325 |
| Antigène | CD249 |
| Applications | Western Blot |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 |
| Conjugué | Unconjugated |
| Espèces cibles | Human |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| Forme | Liquid |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P25815 |
| Immunogène | Recombinant human S100P (immunogen range is 1-95). |
| Expression | S100P |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 6286 |
| Méthode de purification | Protein A |
| Espèces hôtes | Mouse |
| Formule | PBS with 50% glycerol, 0.5% BSA and 0.09% sodium azide |
| Alias de gène | MIG9; Migration-inducing gene 9 protein; protein S100-E; Protein S100-P; S100 calcium binding protein P; S100 calcium-binding protein P; S100E; S100p |
| Clone | K40048_8D5 |
| Antigène | S100P |
Invitrogen™ Cytomegalovirus gH Late Antigen Chimeric Recombinant Rabbit Monoclonal Antibody (MSL-109)
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Rabbit Recombinant Monoclonal Antibody
| Applications | ELISA,Neutralization |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG κ |
| Conjugué | Unconjugated |
| Espèces cibles | Virus |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Immunogène | CMV antigen (Virus antigen batch V2547) prepared from MRC-5 cells infected with the Towne strain of CMV. |
| Classification | Recombinant Monoclonal |
| Méthode de purification | Protein A |
| Espèces hôtes | Rabbit |
| Formule | PBS with 0.02% ProClin 300 |
| Alias de gène | CMV |
| Clone | MSL-109 |
| Antigène | Cytomegalovirus gH Late Antigen Chimeric |
Invitrogen™ CD61 Polyclonal Antibody
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Rabbit Polyclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Conjugué | Unconjugated |
| Espèces cibles | Human,Mouse,Rat |
| Concentration | 0.5 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Numéro d’ordre du gène | O54890, P05106 |
| Immunogène | Recombinant Integrin Beta 3 (ITGb3) (Asp135-Ile377). |
| Expression | ITGB3 |
| Classification | Polyclonal |
| Identification génétique (Entrez) | 16416, 29302, 3690 |
| Méthode de purification | Protein A |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | ITGB3 |
| Formule | PBS with 50% glycerol and 0.05% ProClin 300; pH 7.4 |
| Alias de gène | antigen CD61; BDPLT16; BDPLT2; beta3 integrin; CD61; EGK_08849; glycoprotein GPIIIa; glycoprotein IIIa; GP3A; GPIIIa; GT; INGRB3; integrin beta 3; integrin beta 3 (Cd61); integrin beta-3; integrin beta-3 subunit; integrin subunit beta 3; integrin, beta 3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); ITGB3; platelet glycoprotein IIIa; platelet glycoprotein IIIa integrin subunit beta 3; platelet gpIIIa; platelet membrane glycoprotein IIIa |
| Antigène | CD61 |
Invitrogen™ V5 Tag Recombinant Mouse Monoclonal Antibody (TCM5), Alexa Fluor™ Plus 555
Mouse Recombinant Monoclonal Antibody
| Applications | Flow Cytometry,Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2b κ |
| Conjugué | Alexa Fluor Plus 555 |
| Espèces cibles | Tag |
| Concentration | 1.0 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Classification | Recombinant Monoclonal |
| Méthode de purification | Protein A/G |
| Espèces hôtes | Mouse |
| Formule | Proprietary buffer with 0.008% Bromonitrodioxane, 0.008% Methylisothiazolone; pH 6.8 |
| Alias de gène | simian virus 5 antibody; SPV5gp2; sv5; V5; v-5; V5 Epitope Tag |
| Clone | TCM5 |
| Antigène | V5 Tag |
Invitrogen™ RGR Antibody Cocktail
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Antibody Cocktail
| Applications | Immunohistochemistry (Paraffin) |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG |
| Conjugué | Unconjugated |
| Espèces cibles | Mouse,Rat |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Numéro d’ordre du gène | Q9Z2B3 |
| Immunogène | Synthetic peptide encompassing a sequence within the Extracellular domain of human RGR. The exact sequence is proprietary. |
| Expression | RGR |
| Classification | Cocktail |
| Identification génétique (Entrez) | 306307, 57811 |
| Méthode de purification | Protein A |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | RGR |
| Formule | PBS with no preservative |
| Alias de gène | retinal G protein coupled receptor; Rgr; RGR opsin; RGR-opsin; RP44; RPE retinal G-protein coupled receptor; RPE-retinal G protein-coupled receptor |
| Clone | HL3056+HL3058 |
| Antigène | RGR |
CD45R Monoclonal Antibody (RA3-6B2), NovaFluor™ Blue 760, eBioscience™, Invitrogen™
Rat Monoclonal Antibody
| Applications | Flow Cytometry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2a κ |
| Conjugué | NovaFluor Blue 760 |
| Espèces cibles | Human,Mouse |
| Concentration | 0.1 mg/mL |
| Primaire ou secondaire | Primary |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| Forme | Liquid |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P06800, P08575 |
| Expression | PTPRC |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 19264, 5788 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Rat |
| Formule | PBS with BSA and 0.09% sodium azide; pH 7.2 |
| Alias de gène | B220; Cd45; CD45 antigen; CD45R; GP180; Lca; L-CA; leucocyte common antigen; leukocyte common antigen; leukocyte common antigen A; leukocyte common antigen B; loc; LY5; Ly-5; Lymphocyte antigen 5; lymphocyte common antigen; Lyt-4; membrane tyrosine phosphatase; protein tyrosine phosphatase receptor type C; protein tyrosine phosphatase, receptor type C; protein tyrosine phosphatase, receptor type, C; protein tyrosine phosphatase, receptor type, c polypeptide; Protein tyrosine phosphatase, receptor-type, c polypeptide; Ptprc; Receptor-type tyrosine-protein phosphatase C; RT7; T200; T200 glycoprotein; T200 leukocyte common antigen |
| Clone | RA3-6B2 |
| Antigène | CD45R |
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | Alexa Fluor 514 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P18627 |
| Immunogène | hCD223-FC PFA 4%. |
| Expression | LAG3 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 3902 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | LAG3 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | Activation-induced cytidine deaminase-linked autoimmunity protein; Aida; CD223; FDC; LAG3; LAG-3; Ly66; lymphocyte activating 3; lymphocyte activation gene 3 protein; lymphocyte-activation gene 3; Secreted lymphocyte activation gene 3 protein; sLAG 3; sLAG3; sLAG-3; soluble LAG 3lymphocyte activating 3; soluble LAG3 |
| Clone | 3DS223H |
| Antigène | CD223 (LAG-3) |
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | Alexa Fluor 514 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P01732, P10966 |
| Immunogène | A 13 amino acid synthetic peptide from the C-terminal cytoplasmic domain of alpha chain of human CD8 molecule. |
| Expression | CD8B |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 925, 926 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | Cd8a, CD8B |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | BB154331; CD8; CD8 alpha; CD8 alpha chain; CD8 alpha chain precursor; CD8 antigen; CD8 antigen 32 kDa chain; CD8 antigen 37 kDa chain; CD8 antigen alpha polypeptide; CD8 antigen alpha protein; CD8 antigen alpha protein precursor; CD8 antigen alpha-chain; CD8 antigen beta polypeptide; CD8 antigen beta polypeptide precursor; CD8 antigen beta-chain; CD8 antigen, alpha chain; CD8 antigen, alpha polypeptide; CD8 antigen, alpha polypeptide (p32); CD8 antigen, alpha-chain; CD8 antigen, beta chain; CD8 antigen, beta chain 1; CD8 antigen, beta polypeptide; CD8 antigen, beta polypeptide 1 (p37); CD8 antigen, beta-chain; CD8 beta; CD8 beta chain; CD8 beta-2; CD8a; CD8A antigen alpha; CD8a molecule; CD8A; T-cell surface glycoprotein; CD8alpha; CD8B; CD8b antigen; CD8b molecule; CD8b molecule pseudogene; Cd8b1; CD8beta; CD8BP; fCD8; LEU2; Leu-2; Leu2 T-lymphocyte antigen; leu-2a; Ly-2; LY3; Ly-3; Ly-35; Ly-B; Ly-C; Lymphocyte antigen 3; Lyt2; Lyt-2; Lyt-2.1 lymphocyte differentiation antigen (AA at 100); Lyt3; Lyt-3; MAL; membrane glycoprotein; membrane protein; OKT8 T-cell antigen; OX-8 membrane antigen; p32; P37; RHACD8-4; T cell co-receptor; T lymphocyte surface glycoprotein beta chain; T8 T-cell antigen; T-cell antigen Leu2; T-cell membrane glycoprotein Ly-3; T-cell surface glycoprotein; T-cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 beta chain; T-cell surface glycoprotein Lyt-2; T-cell surface glycoprotein Lyt-3; T-cell surface molecule; T-lymphocyte differentiation antigen T8/Leu-2; type I transmembrane glycoprotein |
| Clone | C8/144B |
| Antigène | CD8 alpha |
Invitrogen™ CD223 (LAG-3) Monoclonal Antibody (3DS223H), Alexa Fluor™ Plus 488
Mouse Monoclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | Alexa Fluor Plus 488 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P18627 |
| Immunogène | hCD223-FC PFA 4%. |
| Expression | LAG3 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 3902 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | LAG3 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | Activation-induced cytidine deaminase-linked autoimmunity protein; Aida; CD223; FDC; LAG3; LAG-3; Ly66; lymphocyte activating 3; lymphocyte activation gene 3 protein; lymphocyte-activation gene 3; Secreted lymphocyte activation gene 3 protein; sLAG 3; sLAG3; sLAG-3; soluble LAG 3lymphocyte activating 3; soluble LAG3 |
| Clone | 3DS223H |
| Antigène | CD223 (LAG-3) |
Invitrogen™ CD8 alpha Monoclonal Antibody (C8/144B), Alexa Fluor™ Plus 555
Mouse Monoclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | Alexa Fluor Plus 555 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P01732, P10966 |
| Immunogène | A 13 amino acid synthetic peptide from the C-terminal cytoplasmic domain of alpha chain of human CD8 molecule. |
| Expression | CD8B |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 925, 926 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | Cd8a, CD8B |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | BB154331; CD8; CD8 alpha; CD8 alpha chain; CD8 alpha chain precursor; CD8 antigen; CD8 antigen 32 kDa chain; CD8 antigen 37 kDa chain; CD8 antigen alpha polypeptide; CD8 antigen alpha protein; CD8 antigen alpha protein precursor; CD8 antigen alpha-chain; CD8 antigen beta polypeptide; CD8 antigen beta polypeptide precursor; CD8 antigen beta-chain; CD8 antigen, alpha chain; CD8 antigen, alpha polypeptide; CD8 antigen, alpha polypeptide (p32); CD8 antigen, alpha-chain; CD8 antigen, beta chain; CD8 antigen, beta chain 1; CD8 antigen, beta polypeptide; CD8 antigen, beta polypeptide 1 (p37); CD8 antigen, beta-chain; CD8 beta; CD8 beta chain; CD8 beta-2; CD8a; CD8A antigen alpha; CD8a molecule; CD8A; T-cell surface glycoprotein; CD8alpha; CD8B; CD8b antigen; CD8b molecule; CD8b molecule pseudogene; Cd8b1; CD8beta; CD8BP; fCD8; LEU2; Leu-2; Leu2 T-lymphocyte antigen; leu-2a; Ly-2; LY3; Ly-3; Ly-35; Ly-B; Ly-C; Lymphocyte antigen 3; Lyt2; Lyt-2; Lyt-2.1 lymphocyte differentiation antigen (AA at 100); Lyt3; Lyt-3; MAL; membrane glycoprotein; membrane protein; OKT8 T-cell antigen; OX-8 membrane antigen; p32; P37; RHACD8-4; T cell co-receptor; T lymphocyte surface glycoprotein beta chain; T8 T-cell antigen; T-cell antigen Leu2; T-cell membrane glycoprotein Ly-3; T-cell surface glycoprotein; T-cell surface glycoprotein CD8 alpha chain; T-cell surface glycoprotein CD8 beta chain; T-cell surface glycoprotein Lyt-2; T-cell surface glycoprotein Lyt-3; T-cell surface molecule; T-lymphocyte differentiation antigen T8/Leu-2; type I transmembrane glycoprotein |
| Clone | C8/144B |
| Antigène | CD8 alpha |
Invitrogen™ Cytokeratin Pan Type I/II Monoclonal Antibody (AE1/AE3), Alexa Fluor™ Plus 555
Mouse Monoclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 |
| Conjugué | Alexa Fluor Plus 555 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P02533, P02538, P04264, P05783, P05787, P08727, P08729, P08779, P12035, P13645, P13646, P13647, P19012, P19013, P35908, Q01546, Q04695, Q7Z794 |
| Immunogène | Human epidermal keratin. |
| Expression | KRT19 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 374454, 3848, 3849, 3850, 3851, 3852, 3853, 3855, 3856, 3858, 3860, 3861, 3866, 3868, 3872, 3875, 3880, 51350 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | KRT1, KRT10, KRT13, KRT14, KRT15, KRT16, KRT17, KRT18, KRT19, KRT2, KRT3, KRT4, KRT5, Krt6a, KRT7, KRT76, KRT77, KRT8 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | 2310016L08Rik; 3300001P10Rik; 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kDa cytokeratin; 60-kDa keratin; 63kDa Keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; AA960620; adult keratin; AI324768; AI528832; AI626930; AI663979; AL022697; alpha keratin; AU019895; AW108092; AW146334; basic epidermal type II cytokeratin (carboxy-terminal region, clone pUF164); BB005427; BCIE; BIE; Card2; cell proliferation-inducing gene 46 protein; CK 2e; CK1; CK-1; CK10; CK-10; CK13; CK-13; CK14; CK-14; CK15; CK-15; CK16; CK-16; CK-17; CK18; CK-18; CK19; CK-19; CK-1B; CK-2e; CK3; CK-3; CK4; CK-4; CK5; CK-5; ck55; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; CK7; CK-7; CK8; CK-8; CYK18; CYK4; CYK8; CYKER; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin 7; cytokeratin 8; cytokeratin 8 (370 AA); cytokeratin endo A; Cytokeratin endo B; cytokeratin otokeratin; cytokeratin type II; cytokeratin type II, component Ib/c; cytokeratin type II, component III; cytokeratin VIB; cytokeratin VII; cytokeratin-1; Cytokeratin-10; cytokeratin-13; Cytokeratin-14; cytokeratin-15; Cytokeratin-16; cytokeratin-17; Cytokeratin-18; cytokeratin-19; Cytokeratin-1B; Cytokeratin-2e; cytokeratin-3; Cytokeratin-4; cytokeratin-5; Cytokeratin-6A; cytokeratin-6B; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; cytokeratin-7; Cytokeratin-8; cytokeratin-A; Cytoskeletal 57 kDa keratin; D130054E02Rik; D15Wsu77e; DDD; DDD1; ear specific cytokeratin; EBS2; ebs3; ebs4; EGK_03684; EGK_03685; EHK; EHK1; Endo B; EndoA; EndoC; epidermal keratin 10; epidermal keratin VII; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; epidermolytic hyperkeratosis; keratosis palmaris et plantaris; epithelial keratin 1; epithelial keratin 10; epithelial keratin 2e; Epithelial keratin-1; Epithelial keratin-2e; EPPK; fgk; fin and gill keratin; FNEPPK; focal non-epidermolytic palmoplantar keratoderma; GK-19; Hair alpha protein; HMWCK; Hom s 5; I79_019823; I79_021074; I79_023185; I79_024335; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K1C1; K1CO; K1CP; K1CS; K2C7; K2C8; K2e; K3; K3 keratin; K4; K5; K6A; K6a keratin; K6C; K6D; K7; K77; K8; Ka10; Ka13; Ka14; Ka15; Ka16; Ka17; Ka19; kamp-keratin derived antimicrobial peptide; Kb1; Kb2; Kb4; Kb7; KDAMP; KER1; Ker10; Ker2; KERA; keratin; keratin 1; keratin 1 (epidermolytic hyperkeratosis); keratin 1, type II; keratin 10; keratin 10 (epidermolytic hyperkeratosis); keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris); keratin 10, type I; keratin 10, type I L homeolog; keratin 10, type I S homeolog; keratin 12, gene 2 S homeolog; keratin 13; keratin 13, type I; keratin 13, type I S homeolog; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 14, type I L homeolog; keratin 15; keratin 15, gene 1 S homeolog; keratin 15, type I; keratin 16; keratin 16 (focal non-epidermolytic palmoplantar keratoderma); keratin 16, type I; keratin 16, type I S homeolog; keratin 17; keratin 17 L homeolog; keratin 17, type I; keratin 17, type I L homeolog; keratin 18; keratin 18, type I; keratin 19; keratin 19 S homeolog; keratin 19 S homeolog; keratin 19; keratin 19, type I; Keratin 1B; keratin 2; keratin 2 (epidermal ichthyosis bullosa of Siemens); keratin 2 epidermis; keratin 2, type II; keratin 24; keratin 2A; keratin 2A (epidermal ichthyosis bullosa of Siemens); keratin 3; keratin 3, type II; keratin 4; keratin 4, type II; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
| Clone | AE1/AE3 |
| Antigène | Cytokeratin Pan Type I/II |
Invitrogen™ CD223 (LAG-3) Monoclonal Antibody (3DS223H), Alexa Fluor™ Plus 555
Mouse Monoclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | Alexa Fluor Plus 555 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P18627 |
| Immunogène | hCD223-FC PFA 4%. |
| Expression | LAG3 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 3902 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | LAG3 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | Activation-induced cytidine deaminase-linked autoimmunity protein; Aida; CD223; FDC; LAG3; LAG-3; Ly66; lymphocyte activating 3; lymphocyte activation gene 3 protein; lymphocyte-activation gene 3; Secreted lymphocyte activation gene 3 protein; sLAG 3; sLAG3; sLAG-3; soluble LAG 3lymphocyte activating 3; soluble LAG3 |
| Clone | 3DS223H |
| Antigène | CD223 (LAG-3) |
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2a |
| Conjugué | Alexa Fluor Plus 555 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P12004 |
| Immunogène | Rat recombinant PCNA polypeptides. |
| Expression | Pcna |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 5111 |
| Méthode de purification | Purified |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | Pcna |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | ATLD2; cb16; Cyclin; DNA polymerase delta auxiliary protein; etID36690.10; fa28e03; fb36g03; HGCN8729; hypothetical protein LOC515499; MGC8367; Pcna; pcna protein; Pcna/cyclin; PCNAR; POL30; Proliferating cell nuclear antigen; wu:fa28e03; wu:fb36g03; YBR0811; YBR088C |
| Clone | PC10 |
| Antigène | PCNA |